Histomorphology of healthy oral mucosa in untreated celiac patients: unexpected association with spongiosis. by Campisi, G. et al.
Histomorphology of healthy oral mucosa in untreated
celiac patients: unexpected association with spongiosis
G. Campisi1, D. Compilato1, G. Iacono2, E. Maresi3, C. Di Liberto1, V. Di Marco4, G. Di Fede5, A. Craxı`4,
A. Carroccio6
1Department of Oral Sciences, University Hospital of Palermo, Palermo, Italy; 2First Division of Pediatric Gastroenterology, ‘‘G. Di
Cristina’’ Hospital of Palermo, Palermo, Italy; 3Department of Human Pathology, University Hospital of Palermo, Palermo, Italy;
4Gastroenterology and Hepatology Unit, University Hospital of Palermo, Palermo, Italy; 5Department of Medical Oncology,
University Hospital of Palermo, Palermo, Italy; 6Department of Internal Medicine, University Hospital of Palermo, Palermo, Italy
BACKGROUND: The jejunal mucosa is the major site
involved in celiac disease, but modifications have also
been found in the gastric, rectal and esophageal mucosa.
Few studies have focused on the histomorphological
features of the oral mucosa in celiac disease patients. Our
objectives were: (i) to assess the presence, quality and
intensity of lymphocytic infiltrate in clinically healthy oral
mucosa and its relation to celiac disease severity (villous
height to crypt depth ratio); and (ii) to detect any other
histological features connected to celiac disease.
METHODS: Twenty-one untreated celiac disease patients
(age range 13–68 years)with clinically healthy oralmucosa
were enrolled and compared with 14 controls. Intestinal
and oral biopsies were carried out and specimens were
evaluated after staining with hematoxylin and eosin.
RESULTS: Intra-epithelial lymphocyte B and T infiltrates
of the oral mucosa were found to be similar in both
groups; likewise, intensity of the lymphocytic infiltrate in
the lamina propria was similar in both groups and was not
related to intestinal damage; important signs of spongi-
osis were found to be more significantly present in celiac
disease patients compared with controls (P = 0.0002).
CONCLUSIONS: Our study showed that the healthy oral
mucosa of untreated patients does not reflect the intes-
tinal damage by celiac disease, but it is unexpectedly
affected by spongiosis, as being detected for the first
time in the literature. This latter feature could be related
to gliadin ingestion and could contribute to explain the
higher susceptibility of celiac disease patients to suffering
from oral mucosa lesions.
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Introduction
Celiac disease (CD), the most common food-sensitive
enteropathy in humans, can be deﬁned as a chronic
inﬂammatory intestinal disease that aﬀects the small
intestinal mucosa, triggered by the ingestion of gluten-
containing cereals (i.e., wheat, barley, rye) in genetically
predisposed subjects (1–3). Its prevalence is estimated in
the range of 1:85–1:300 both in Europe and in the USA
(4–11). It is known that CD results from an inappro-
priate T cell-mediated immune response against ingested
gluten (1, 12, 13), in fact the activation of the intestinal
intraepithelial lymphocytes and lymphocytes in the
lamina propria produces peculiar damages of the small
intestinal mucosa observed in the intestinal biopsy
specimens. Normal small intestinal mucosa exhibits
digitate villi, leaf forms and ridges. The villi vary in
size, shape, and height but their heights are usually three
times more than their widths. The classic histological
intestinal lesion of a patient with untreated CD is
characterized by villous atrophy (partial, subtotal or
total) with crypt hyperplasia (14), increase in lamina
propria and intraepithelial lymphocytes (the normal gut
contains 10–30 intraepithelial lymphocytes ⁄100 entero-
cytes), extensive surface cell damage and inﬂammatory
inﬁltration of the lamina propria (15) (Fig. 1).
Although the small intestinal mucosa represents the
main site of the gut involved in CD, other mucosal
surfaces belonging to the gastrointestinal (GI) tract and
to the gut-associated lymphoid tissue (GALT) can also
be involved (16–18). In fact, changes have been observed
in the gastric (19, 20), terminal ileal (21) and rectal
mucosa (16, 22–26); rectal mucosa, furthermore, has
also been used for gluten challenges (22, 27–31). Finally,
esophageal involvement has also been shown in patients
with untreated CD (19, 32). All this demonstrates that
gluten-driven T-cell activation is not restricted to the
proximal part of the intestine but is present in the whole
intestine.
A site which could be studied less invasively is the
mouth, as it is the ﬁrst part of the GI system and a part
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of GALT; in fact, it is well known that the oral mucosa
can be aﬀected by clinical manifestations in patients
with CD (33–41). Furthermore, it has been shown that
inﬂammatory changes occur after oral supramucosal
application and submucosal injection of gliadin in the
oral mucosa of CD patients (42–44) and a recent study
reported that the oral mucosa contributes to anti-
endomysial antibodies (EMA) and anti-tissue transglu-
taminase (tTG) antibodies production in untreated CD
patients (45). However, currently only few data exist on
the histological aspects of oral mucosa in patients with
CD.
Hence, the major aim of this study was to study the
clinically healthy oral mucosa of CD patients: (i) to
assess the presence, quality (B ⁄ T lymphocytes) and
intensity of lymphocytic inﬁltration and its relation to
the severity of the intestinal histological damage; and
(ii) to detect any other histological aspect which could
be linked to CD.
Materials and methods
The test group consisted of 21 newly diagnosed, and
untreated CD patients (15 females and 6 males, median
age 36 ± 14 years; range 13–68 years) consecutively
enrolled in a secondary hospital setting, between June
2004 and May 2005.
During the same period, 14 subjects (10 females and 4
males, median age 39 ± 15 years; range 12–66 years),
matched for age and gender, were consecutively recruited
from patients with symptoms compatible with CD
diagnosis (weight loss, failure to thrive, anemia, chronic
diarrhea, abdominal pain, dyspepsia, gastro-esophageal
reﬂux and abdominal meteorism), but with negative
serum assays for CD diagnosis. All underwent eso-
phago-gastro-duodenoscopy (EGDS) with duodenal
histological examination. All showed normal histology
of the intestinal mucosa and were considered control
subjects.
Celiac disease diagnosis was based on positive sero-
logy [IgA and ⁄or IgG anti-tTG, IgA and ⁄or IgG EMA]
together with positive histological evidence of villous
atrophy with crypt hyperplasia and increase in intraepi-
thelial lymphocytes, and the disappearance of symptoms
and normalization of serum anti-tTG and ⁄or EMA after
a gluten-free diet (GFD) was imposed (46).
Test and control patients were recruited after a careful
clinical examination of the entire oral cavity and
subjects showing soft tissue lesions (e.g., aphthous-like
ulcers, non-speciﬁc atrophic glossitis, mucosal ery-
thema) were excluded from this study.
Informed consent was obtained from all of the
patients involved in the study or from their parents in
the case of pediatric patients.
Intestinal and oral biopsies, histological and
immunohistochemical evaluation
Following general anesthesia (in children) or conscious
sedation with meperidine ⁄pethidine 1 mg ⁄kg i.v. and
midazolam 0.05–0.1 mg ⁄kg i.v. (in adults), EGDS were
performed with standard pediatric or adult video-
colonoscopes (Olympus, Milan, Italy). At least four
duodenal biopsy samples were obtained from each
patient.
Both 21 untreated CD patients and 14 controls
underwent oral mucosal biopsy. Biopsy specimens
were taken at the same time as the EGDS in the
children and under local anesthesia (Xylocaine 2%,
adrenaline 1:100.000) in adults. The specimens were
always taken by two of the authors (DC and CDL)
A
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Figure 1 Histological features of small intestinal mucosa in patients
with untreated CD. (A) Normal mucosa. (B) Partial villous atrophy.
(C) Total villous atrophy.
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from a clinically healthy buccal mucosa adjacent to
the right second molar tooth region, beneath the
occlusal line. The biopsies were performed by punch-
ing (6 mm in diameter punch biopsy) or by incision
with cold knife.
The intestinal and oral biopsy specimens were imme-
diately ﬁxed in 10% neutral-buﬀered formalin for 2 h,
washed in water for 1 h, dehydrated in graded ethanol
(60%, 80%, 90%, 95% and, 100%) and after perme-
ation in xylene, embedded in paraﬃn using the standard
procedures. The formalin-ﬁxed, paraﬃn-embedded sam-
ples were cut into 5-lm-thick sections on a microtome
with a disposable blade. The sections of the intestinal
mucosa were stained with hematoxylin and eosin (H&E)
for standard evaluation. From each specimen of the oral
mucosa, three sections were obtained: one convention-
ally stained with hematoxylin-and-eosin and the other
two treated with 4 KB5 monoclonal antibodies against-
CD45RA and with UCHL1 monoclonal antibodies
against-CD45RO (Dako, Milan, Italy) to evaluate
lymphocyte inﬁltrates B and T, respectively.
Intestinal histological specimens were deﬁned compat-
ible with the clinical diagnosis of CD when there was
both intraepithelial lymphocytosis (at least 40 lympho-
cytes ⁄100 enterocytes) (47) and a villous height to crypt
depth ratio (V ⁄C)<2.5. Furthermore, based on this ratio,
a CD histological grading was deﬁned: Grade 1 = V ⁄C
2–2.5; Grade 2 = V ⁄C 1–2; Grade 3 = V ⁄C 1–0.5; and
Grade 4 V ⁄C < 0.5 (48, 49).
All oral biopsy slides were examined blindly by one of
the authors (EM). CD3+ intraepithelial lymphocytes
were examined using mAb Leu-4 (Becton Dickinson,
San Jose, CA). B lymphocytes were detected in paraﬃn-
embedded sections using monoclonal antibodies to
CD20 (Dako a ⁄s, Glostrup, Denmark) and T lympho-
cytes with monoclonal antibodies to CD45RO
(Dako a ⁄s).
The densities of CD3+, CD20+ and CD45RO+ cells
were light microscopically counted in the epithelium and
in the lamina propria using an ocular graticule of
0.10 · 0.10 mm at ·400 magniﬁcation. Ten ﬁelds were
counted in the buccal epithelium and lamina propria
immediately below the basement membrane. The results
were given as cells ⁄mm2. The intensity of the lamina
propria lymphocytic inﬁltrate in the H&E stainings was
arbitrarily graded as none (0), low (1), moderate (2) or
severe (3).
Furthermore, the presence of a spongiotic tissue
reaction was assessed. Spongiotic reaction was deﬁned
as the presence of intraepidermal and intercellular
oedema and labeled spongiosis’.
Statistical analysis
Data were analyzed by means of STATVIEW for Win-
dows (SAS Inc v. 5.0.1, Cary, NC, USA). To measure
the association level, odds ratio (OR) and the 95%
corresponding test-based conﬁdence interval (CI) were
calculated. Chi-square test was used to assess statistical
diﬀerences between categorical variables. The Mann–
Whitney U-test and Spearman rank correlation coeﬃ-
cient (Spearman’s rho) were used to calculate diﬀerences
between non-parametric continuous variables. Student’s
t test was used for parametric continuous variables. In
all of the evaluations, P-values £0.05 were considered
statistically signiﬁcant.
Results
Table 1 shows the lymphocyte (B and T) counts in the
oral mucosa of the 21 CD patients and of the 14
controls. No diﬀerences were observed in CD3+ count
or B- and T-lymphocyte counts either in the epithelium
or in the lamina propria of the oral mucosa in CD
patients and in controls, although in the lamina propria
of the CD patients there was a trend towards a higher
number of CD3+ and CD45RO lymphocytes.
Furthermore, there was no relationship between the
intensity of lymphocytic inﬁltration in the oral mucosa
and severity of intestinal mucosal damage, evaluated
as villi ⁄crypts ratio (r = 1.03, P = 0.8) (Table 2).
A very frequent histomorphological ﬁnding was
spongiosis of the oral mucosal epithelium, observed
in 19 ⁄21 (90%) of CD patients and only in 4 ⁄14 (29%)
of controls [P = 0.0002; v2 = 14.29; OR = 23.75
(95%CI = 3.69:152.9)] (Fig. 2). This spongiotic reac-
tion was characterized by the presence of intraepidermal
and intercellular oedema; intercellular spaces were
widened with an elongation of the intercellular bridges.
The foci of spongiosis were also characterized by a
mild lymphocytic inﬁltrate, but not by the presence of
eosinophils or neutrophils. These lesions were exclu-
sively microscopic without any corresponding identiﬁ-
able vesicles on the oral mucosal surface (Figs 3–4).
Discussion
Although histological and clinical features of the small
intestinal mucosa in CD are well known, the involve-
ment of the other mucosal surfaces belonging to the GI
tract and to the GALT has been neglected. It has been
demonstrated that in CD patients, gluten-driven T-cell
activation is not restricted to the proximal part of the
intestine, but is present in the whole intestine. In fact,
the dissemination of the immune eﬀector cells involves
very distant sites of the GALT including the oral and
rectal mucosa (17), the two extremities of the GI tract.
Table 1 Number of T- and B-lymphocytes in the oral epithelium and
in the lamina propria of 21 untreated CD patients and of 14 controls
(intra-epithelial lymphocytes were counted as cells ⁄mm2; lamina
propria lymphocytes as cells · 100 ⁄mm2)
CD patients Controls
Intra-epithelial
CD3+ 152 ± 121 168 ± 110
B-lymphocytes 43 ± 42 38 ± 45
T-lymphocytes 121 ± 102 131 ± 98
Lamina propria
CD3+ 5.1 ± 4.7 3.1 ± 3.8
B-lymphocytes 0.8 ± 0.9 0.6 ± 0.7
T-lymphocytes 4.5 ± 2.9 3.8 ± 3.9
Data are given as mean ± SD.
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Histological changes have already been shown in the
gastric (19, 20), terminal ileal (21), rectal mucosa (16, 22,
26), and esophageal mucosa (19, 32) of CD patients.
Although it is widely reported that in CD patients, the
mouth can also be aﬀected by several clinical manifes-
tations such as recurrent aphthous stomatitis (RAS) (34,
38, 40, 50), dental enamel defects (39, 51–54) and non-
speciﬁc atrophic glossitis (41), data about histological
features of clinically healthy oral mucosa in patients
with CD are few and often contrasting (41, 42, 55).
The healthy mucosa of the mouth is quite diﬀerent
from that of the rest of the GI tract; the oral mucosa of
the lips, buccal, and ﬂoor areas are covered by a non-
keratinized stratiﬁed epithelium, while the lining of the
stomach and small and large intestine consists of a
simple epithelium composed of only a single layer of
cells (56). Although the structure of the oral mucosa
diﬀers from that of the bowel from an immunological
point of view, the mouth is situated at the beginning of
the GI system and, as part of it, is considered to belong
to the GALT. Consequently, after antigen activation,
proliferation and partial diﬀerentiation in the GALT,
memory B cells and T cells migrate to other parts of the
GALT, including the oral mucosa lymphoid tissues (17).
There, these cells, in sensitized CD patients, may easily
react to gluten and its peptides; in fact, more recent
ﬁndings have suggested that the oral mucosa of CD
patients could be useful to evaluate response to a gluten-
challenge (42).
Based on these considerations, we expected the
healthy oral mucosa of untreated CD patients to behave
in a similar way to the small bowel mucosa. However,
our results did not conﬁrm our initial hypothesis and
we did not ﬁnd any signiﬁcant presence of B and T
lymphocytes inﬁltrate or any relationship with severity
of CD in the oral mucosa of our study group.
These data are in agreement with a study performed
in Finland in which untreated CD patients did not diﬀer
from controls in terms of T cell number in the buccal
mucosa (55). The behavior of the oral mucosa of our
patients with untreated CD did not mirror that of the
small intestinal mucosa in which an increase of T cells
generally occurs and the density of these cells decreases
on a GFD. An explanation of this result might be that in
patients with untreated CD, a gluten-containing diet
induces a sequestration of lymphocytes to the intestinal
mucosa and hence a concentration’ of the inﬂammatory
cells with greater mucosal damage at this site (57). This
may result in a low intensity of lymphocytic inﬁltrate in
other mucosal tissues belonging to the GALT, including
the oral mucosa (41, 58).
The novel ﬁnding of our research is the detection of
spongiosis’ in the biopsy samples of the clinically
healthy oral mucosa of untreated CD patients. We
found epithelial spongiosis in almost all the study group
(90%) with a crude OR of about 23.
In general, spongiotic tissue is characterized by the
presence of intracellular and intercellular oedema.
Indeed, spongiosis is considered only a histopatholog-
ical concept and not as a clinical entity, although several
diseases present such a tissue reaction (59).
Spongiotic reaction has been found in several skin
lesions (60–64) and in some oral diseases, such as oral
melanoacanthosis (melanoacanthoma) (65), oral psori-
asis (66), allergic contact stomatitis (67), plasma cell
gingivitis, intra-oral ﬁxed drug eruption, leukoedema
and white sponge nevus (68). In most of these oral
lesions, the pathogenetic mechanism involved in the
collection of the intraepithelial ﬂuid is not clear and
remains to be elucidated: spongiosis could be caused by
extravasations of ﬂuids from blood vessels located in
the lamina propria or by the presence of an osmotic
gradient developed towards the epithelium, drawing
ﬂuid into it subsequent to various immunological
reactions (59).
Spongiosis is also a histopathological feature found in
the epithelium at the margin of an aphthous ulcer (68);
moreover, the pre-ulcerative stage in the pathogenesis of
RAS is characterized by oedema of the epithelium and
keratinocyte vacuolization (69), and therefore by spong-
iosis.
However, as several conditions, like the presence of
mucopolysaccharidic materials may simulate spongiosis,
we demonstrate that this histomorphologic feature is not
associated with the accumulation of PAS-positive sub-
stances (e.g., acid mucopolysaccharides) within the
cytoplasm of the keratinocytes with spongiotic aspect
(Fig. 5).
We underline that our ﬁnding of massive spongiosis
was found in the otherwise healthy oral epithelium of
Table 2 Relationship between the intensity of lamina propria lym-
phocyte inﬁltration in the oral mucosa and the severity of intestinal
mucosa damage
Intestinal CD histological grading Number of
CD patientsGrade 1 Grade 2 Grade 3 Grade 4
Grading of oral lymphocytic inﬁltrate
None 0 0 1 5 6
Low 0 2 3 9 14
Moderate 0 0 0 0 0
Intense 0 0 0 1 1
Figure 2 Normal oral mucosa. Absence of spongiosis in the oral
epithelium.
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CD patients. Noteworthy, this ﬁnding may support the
hypothesis that spongiosis represents histological evi-
dence or a key of the well-known higher susceptibility of
these patients to suﬀering from RAS. The continuous
contact of the gluten-containing foods with the oral
mucosa could provoke epithelial spongiotic changes,
characterized ﬁrst by intracellular oedema and then by
intercellular oedema with elongation of the intercellular
bridges. The increase of intercellular oedema leads to the
formation of intraepithelial micro-vesicles and there-
after breaking oﬀ to form ulcer. According to this
theory, patients not adhering to GFD would be more
likely to suﬀer from RAS, as actually veriﬁed by our
research group (70).
The lack of lymphocytes inﬁltration of the oral
mucosa cannot exclude that other inﬂammatory mech-
anisms, cells and mediators play a role in determining an
inﬂammatory condition that determines the onset of
spongiosis.
A further datum comes from a recent study (71) in
which authors showed that the clinically healthy oral
mucosa of patients who underwent allogeneic hemato-
poietic stem cell transplantation presents the same
Figure 3 Histological features of healthy oral mucosa in different celiac patients. Diffuse distension and vacuolation (spongiosis) of the
intermediate and superﬁcial acanthocytes and their overlapping.
Figure 4 Marked overlapping of the acanthocytes.
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histological changes as those observed in biopsy spec-
imens of patients with clinical evidence of oral chronic
graft-versus-host disease (c-GVHD); in this case, a basal
cell hydropic degeneration resembling the spongiosis
reported by us was observed.
This latter study, as well as ours, proposes that oral
biopsy could represent an important and useful diag-
nostic method for predicting the clinical onset of oral
lesions in patients with some systemic diseases, such as
CD or c-GVHD, especially if we consider that the oral
cavity represents a site with less invasiveness and with an
easy access.
In conclusion, our ﬁndings conﬁrm that the oral
mucosa of untreated CD cannot be considered a coun-
terpart of the jejunal mucosa, at least in terms of B and
T lymphocyte inﬁltrate.
The ﬁnding of oral mucosal spongiosis, to the best of
our knowledge, is the ﬁrst reported for CD; its meaning is
not deﬁnitively explained, but it could provide the well-
known susceptibility of CD patients to RAS onset. In
these patients with untreated CD, oral mucosal spongi-
osis may be related to histological phenomena induced by
gliadin ingestion. Hence, future aims could be to demon-
strate whether oral spongiosis is a reliable sign of naı¨ve
CD, and whether it should be used as a marker of
untreated CD, an indicator of non-adherence to GFD or
a condition present despite strict adherence to GFD.
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